We aim to explore the internal mechanism that leads to the development of mild or severe COVID‐19 symptoms through a comprehensive analysis of the gene expression profile of ACE2‐positive bronchial epithelial cells and to identify new genes that can serve as therapeutic targets. The gene discussed is ACE2; the disease is COVID-19.